Veterinary medicines European public assessment report (EPAR): Versican Plus L4, Canine leptospirosis vaccine (inactivated), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD, Newcastle disease, infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Vaxxitek HVT+IBD, Infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Poulvac E. coli, Escherichia coli aroA gene deleted, type O78, strain EC34195 (live), Status: Authorised

Veterinary medicines European public assessment report (EPAR): Porcilis PCV M Hyo, porcine circovirus type 2 ORF2 subunit antigen,mycoplasma hyopneumoniae vaccine (inactivated), Status: Authorised

Human medicines European public assessment report (EPAR): Byetta, exenatide, Date of authorisation: 20/11/2006, Revision: 30, Status: Authorised

European Shortages Monitoring Platform (ESMP): Implementation guide for national competent authorities

European Shortages Monitoring Platform (ESMP): Implementation guide for marketing authorisation holders

PSUSA/00000300/202403

Human medicines European public assessment report (EPAR): Pemetrexed Sandoz, pemetrexed, Date of authorisation: 18/09/2015, Revision: 9, Status: Withdrawn (authorisation)